Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-20Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-05-03A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-03-12Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experienceJournal of Psychopharmacology · 2026-01-25The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-24An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2025-12-31Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinEuropean Journal of Neuroscience · 2025-11-30Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-01Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysisTranslational Psychiatry · 2025-08-28Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology · 2025-08-28“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorderNeuropharmacology · 2025-08-20Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Is there mush-room to improve the environmental sustainability of psilocybin production?Journal of CO2 Utilization · 2025-06-09In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assaysDrug Metabolism and Pharmacokinetics · 2025-05-31Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-04-30Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybinEuropean Journal of Pharmacology · 2025-01-26When death is desired: A case of MAiD & the CL psychiatrist.Palliative & supportive care · 2025-01-20Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-08Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-09-19B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-11Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03Effect of a single psilocybin treatment on Fos protein expression in male rat brainNeuroscience · 2024-01-03Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphereAuthorea Preprints · 2023-11-16Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-20Evidence versus expectancy: the development of psilocybin therapyBJPsych Bulletin · 2023-05-28Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020Journal of Psychopharmacology · 2023-03-05Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparationJournal of Affective Disorders · 2023-01-24Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathwayFungal Genetics and Biology · 2022-12-28Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-28Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS Omega · 2022-07-04Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.Journal of Psychopharmacology · 2022-04-06The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta Crystallographica Section C Structural Chemistry · 2021-12-31P.0623 The clinical relevance of the pharmacokinetics of psilocybinEuropean Neuropsychopharmacology · 2021-11-30Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Psilocybin: From Serendipity to Credibility?Frontiers in Psychiatry · 2021-04-20Psilacetin derivatives: fumarate salts of the meth-yl-ethyl, meth-yl-allyl and diallyl variants of the psilocin prodrug.Acta Crystallographica Section E Crystallographic Communications · 2021-01-07Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23Oregon's Pioneering Effort to Enact State Law to Allow Access to PsilocybinSSRN Electronic Journal · 2020-08-13Psilocybin occasioned mystical-type experiences.Unknown journal · 2020-06-22Emotions and brain function are altered up to one month after a single high dose of psilocybinScientific Reports · 2020-02-09Medicinal use of psilocybin: Reducing restrictions on research and treatment.Unknown journal · 2019-12-31The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocinActa Crystallographica Section E Crystallographic Communications · 2019-08-14Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrugActa Crystallographica Section E Crystallographic Communications · 2019-05-30T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.Future medicinal chemistry · 2019-01-31Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.Journal of Psychopharmacology · 2018-09-04Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-23Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of Psychopharmacology · 2016-11-30Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.Frontiers in Psychology · 2016-05-18Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Psilocybin and Obsessive Compulsive Disorder.Journal of Psychoactive Drugs · 2014-10-31Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of Psychopharmacology · 2013-06-18Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-06Patterns of recreational drug use at dance events in Edinburgh, Scotland.Unknown journal · 2001-06-30Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbitUA Campus Repository (The University of Arizona) · 1976-12-31AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)The Journal of Pharmacology and Experimental Therapeutics · 1963-03-31